* Race joint venture with targimmune-rac.ax

* Executed a letter of intent with Targimmune Therapeutics to enter into a joint venture

* JV will focus on developing new and improved cancer therapies based on combining bisantrene with Targimmune's targeted cancer therapy technology Source text for Eikon: Further company coverage: